BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Neuron
,
Pharmacogenetics
,
Fluoxetine
,
rs2230926
,
DNMT1
,
calcium channel activity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
elesclomol
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
FDX1-dependent and independent mechanisms of elesclomol-mediated intracellular copper delivery.
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy.
DLAT as a Cuproptosis Promoter and a Molecular Target of Elesclomol in Hepatocellular Carcinoma.
Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD-L1 …
Elesclomol elevates cellular and mitochondrial iron levels by delivering copper to the iron import m…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelia…
Study Elesclomol Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia
A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid T…
Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Doce…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ